We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIOCHROM LTD

Biochrom Ltd. is a leading manufacturer of scientific instruments with over 40 years experience. The Biochrom Group c... read more Featured Products: More products

Download Mobile App




LAMP Technique Detects Toxoplasmosis

By LabMedica International staff writers
Posted on 16 Jun 2015
The analytical sensitivity and specificity of a newly described DNA amplification technique, loop-mediated isothermal amplification (LAMP), has been tested for the diagnosis of toxoplasmosis. More...


Toxoplasma gondii is an obligate intracellular protozoan parasite capable of infecting humans and all warm blooded animals worldwide and despite the high rate of infection in human, infections often remain asymptomatic in immunocompetent individuals.

Scientists at the Lorestan University of Medical Sciences (Khorramabad, Iran) prepared T. gondii tachyzoites from peritoneal exudate from infected mice. Extraction of DNA was performed using the classical phenol chloroform extraction, and two commercial DNA extraction kits. A Nano-spectrophotometer WPA-Biowave II (Biochrom; Cambridge, UK) was used to determine the concentration and quality of the DNA. Each T. gondii one 80-Mbp genome was assumed equal about 80 fg DNA.

The analytical sensitivity of LAMP and nested-polymerase chain reaction (PCR) was obtained against 10-fold serial dilutions of T. gondii DNA ranging from 1 ng to 0.01 fg. DNA samples of other parasites and human chromosomal DNA were used to determine the specificity of molecular assays. The team analyzed the sensitivity, specificity and technical performances of the LAMP and nested-PCR assays by targeting the two repetitive conserved regions (RE and B1) in the Toxoplasma genome for the molecular diagnosis of T. gondii infection.

After testing LAMP and nested-PCR in duplicate, the detection limit of RE-LAMP, B1-LAMP, RE-nested PCR and B1-nested PCR assays was one fg, 100 fg, 1 pg and 10 pg of T. gondii DNA respectively. All the LAMP assays and nested PCRs were 100% specific. The RE-LAMP assay was the most sensitive for the detection of T. gondii DNA.

The authors concluded the LAMP technique has a greater sensitivity for detection of T. gondii. Furthermore, these findings indicate that primers based on the RE are more suitable than those based on the B1 gene. However, the B1-LAMP assay has potential as a diagnostic tool for detection of T. gondii. Because of its simplicity, sensitivity, and specificity, LAMP is suggested as an appropriate method for the routine molecular diagnosis of toxoplasmosis. The study was published on May 20, 2015, in the Asian Pacific Journal of Tropical Medicine.

Related Links:

Lorestan University of Medical Sciences 
Biochrom 




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.